 | • レポートコード：GIR201100692 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、抗凝固剤の世界市場を調査対象にし、抗凝固剤の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（血小板凝集阻害剤（PAI）、低分子ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、直接因子Xa阻害剤（DFXa）、ビタミンK拮抗薬（VKA）、その他）、用途別分析（VTE、ACS/MI、AF、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Sanofi、Aspen、Johnson & Johnson、Bayer、Bristol-Myers Squibb、Boehringer Ingelheim、Otsuka、AstraZeneca、Genentech (Roche)、Lilly、Pfizer、Daiichi Sankyo、The Medicines Company ・メーカー別販売量、売上、市場シェア ・抗凝固剤の地域別市場分析 ・抗凝固剤の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・抗凝固剤のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・抗凝固剤のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・抗凝固剤の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・抗凝固剤の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・抗凝固剤の種類別市場規模2015-2020：血小板凝集阻害剤（PAI）、低分子ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、直接因子Xa阻害剤（DFXa）、ビタミンK拮抗薬（VKA）、その他 ・抗凝固剤の用途別市場規模2015-2020：VTE、ACS/MI、AF、その他 ・抗凝固剤の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Anticoagulants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Anticoagulants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.6%% in the forecast period of 2020 to 2025 and will expected to reach USD 1267.2 million by 2025, from USD 910.6 million in 2019.
Market segmentation
Anticoagulants market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anticoagulants market has been segmented into
Platelet aggregation inhibitors (PAI)
Low-molecular-weight Heparin (LMWH)
Direct thrombin inhibitor (DTI)
Direct factor Xa inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
By Application, Anticoagulants has been segmented into:
VTE
ACS/MI
AF
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anticoagulants market presented in the report. This section sheds light on the sales growth of different regional and country-level Anticoagulants markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anticoagulants market.
The report offers in-depth assessment of the growth and other aspects of the Anticoagulants market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Anticoagulants Market Share Analysis
Anticoagulants competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anticoagulants sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anticoagulants sales, revenue and market share for each player covered in this report.
The major players covered in Anticoagulants are:
Sanofi
Aspen
Johnson & Johnson
Bayer
Bristol-Myers Squibb
Boehringer Ingelheim
Otsuka
AstraZeneca
Genentech (Roche)
Lilly
Pfizer
Daiichi Sankyo
The Medicines Company
Among other players domestic and global, Anticoagulants market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anticoagulants product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anticoagulants, with price, sales, revenue and global market share of Anticoagulants in 2018 and 2019.
Chapter 3, the Anticoagulants competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anticoagulants breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Anticoagulants sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Anticoagulants Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anticoagulants Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Platelet aggregation inhibitors (PAI)
1.2.3 Low-molecular-weight Heparin (LMWH)
1.2.4 Direct thrombin inhibitor (DTI)
1.2.5 Direct factor Xa inhibitors (DFXa)
1.2.6 Vitamin K antagonists (VKA)
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Anticoagulants Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Other
1.4 Overview of Global Anticoagulants Market
1.4.1 Global Anticoagulants Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Aspen
2.2.1 Aspen Details
2.2.2 Aspen Major Business
2.2.3 Aspen SWOT Analysis
2.2.4 Aspen Product and Services
2.2.5 Aspen Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb SWOT Analysis
2.5.4 Bristol-Myers Squibb Product and Services
2.5.5 Bristol-Myers Squibb Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Product and Services
2.6.4 Boehringer Ingelheim Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Otsuka
2.7.1 Otsuka Details
2.7.2 Otsuka Major Business
2.7.3 Otsuka Product and Services
2.7.4 Otsuka Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Product and Services
2.8.4 AstraZeneca Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Genentech (Roche)
2.9.1 Genentech (Roche) Details
2.9.2 Genentech (Roche) Major Business
2.9.3 Genentech (Roche) Product and Services
2.9.4 Genentech (Roche) Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Lilly
2.10.1 Lilly Details
2.10.2 Lilly Major Business
2.10.3 Lilly Product and Services
2.10.4 Lilly Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Product and Services
2.11.4 Pfizer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Daiichi Sankyo
2.12.1 Daiichi Sankyo Details
2.12.2 Daiichi Sankyo Major Business
2.12.3 Daiichi Sankyo Product and Services
2.12.4 Daiichi Sankyo Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 The Medicines Company
2.13.1 The Medicines Company Details
2.13.2 The Medicines Company Major Business
2.13.3 The Medicines Company Product and Services
2.13.4 The Medicines Company Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anticoagulants Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anticoagulants Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anticoagulants Manufacturer Market Share in 2019
3.3.2 Top 6 Anticoagulants Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anticoagulants Sales, Revenue and Market Share by Regions
4.1.1 Global Anticoagulants Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anticoagulants Revenue and Market Share by Regions (2015-2020)
4.2 North America Anticoagulants Sales and Growth Rate (2015-2020)
4.3 Europe Anticoagulants Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anticoagulants Sales and Growth Rate (2015-2020)
4.5 South America Anticoagulants Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anticoagulants Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anticoagulants Sales, Revenue and Market Share by Country
5.1.1 North America Anticoagulants Sales and Market Share by Country (2015-2020)
5.1.2 North America Anticoagulants Revenue and Market Share by Country (2015-2020)
5.2 United States Anticoagulants Sales and Growth Rate (2015-2020)
5.3 Canada Anticoagulants Sales and Growth Rate (2015-2020)
5.4 Mexico Anticoagulants Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anticoagulants Sales, Revenue and Market Share by Country
6.1.1 Europe Anticoagulants Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anticoagulants Revenue and Market Share by Country (2015-2020)
6.2 Germany Anticoagulants Sales and Growth Rate (2015-2020)
6.3 UK Anticoagulants Sales and Growth Rate (2015-2020)
6.4 France Anticoagulants Sales and Growth Rate (2015-2020)
6.5 Russia Anticoagulants Sales and Growth Rate (2015-2020)
6.6 Italy Anticoagulants Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anticoagulants Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anticoagulants Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anticoagulants Revenue and Market Share by Regions (2015-2020)
7.2 China Anticoagulants Sales and Growth Rate (2015-2020)
7.3 Japan Anticoagulants Sales and Growth Rate (2015-2020)
7.4 Korea Anticoagulants Sales and Growth Rate (2015-2020)
7.5 India Anticoagulants Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anticoagulants Sales and Growth Rate (2015-2020)
7.7 Australia Anticoagulants Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anticoagulants Sales, Revenue and Market Share by Country
8.1.1 South America Anticoagulants Sales and Market Share by Country (2015-2020)
8.1.2 South America Anticoagulants Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anticoagulants Sales and Growth Rate (2015-2020)
8.3 Argentina Anticoagulants Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anticoagulants Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anticoagulants Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anticoagulants Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anticoagulants Sales and Growth Rate (2015-2020)
9.3 Turkey Anticoagulants Sales and Growth Rate (2015-2020)
9.4 Egypt Anticoagulants Sales and Growth Rate (2015-2020)
9.5 South Africa Anticoagulants Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anticoagulants Sales and Market Share by Type (2015-2020)
10.2 Global Anticoagulants Revenue and Market Share by Type (2015-2020)
10.3 Global Anticoagulants Price by Type (2015-2020)
11 Global Anticoagulants Market Segment by Application
11.1 Global Anticoagulants Sales Market Share by Application (2015-2020)
11.2 Global Anticoagulants Revenue Market Share by Application (2015-2020)
11.3 Global Anticoagulants Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anticoagulants Sales, Revenue and Growth Rate (2021-2025)
12.2 Anticoagulants Market Forecast by Regions (2021-2025)
12.2.1 North America Anticoagulants Market Forecast (2021-2025)
12.2.2 Europe Anticoagulants Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anticoagulants Market Forecast (2021-2025)
12.2.4 South America Anticoagulants Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anticoagulants Market Forecast (2021-2025)
12.3 Anticoagulants Market Forecast by Type (2021-2025)
12.3.1 Global Anticoagulants Sales Forecast by Type (2021-2025)
12.3.2 Global Anticoagulants Market Share Forecast by Type (2021-2025)
12.4 Anticoagulants Market Forecast by Application (2021-2025)
12.4.1 Global Anticoagulants Sales Forecast by Application (2021-2025)
12.4.2 Global Anticoagulants Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Anticoagulants Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anticoagulants by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anticoagulants Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Anticoagulants Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Anticoagulants Major Business
Table 10. Sanofi Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 11. Sanofi SWOT Analysis
Table 12. Sanofi Anticoagulants Product and Services
Table 13. Sanofi Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Aspen Basic Information, Manufacturing Base and Competitors
Table 15. Aspen Anticoagulants Major Business
Table 16. Aspen Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 17. Aspen SWOT Analysis
Table 18. Aspen Anticoagulants Product and Services
Table 19. Aspen Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 21. Johnson & Johnson Anticoagulants Major Business
Table 22. Johnson & Johnson Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 23. Johnson & Johnson SWOT Analysis
Table 24. Johnson & Johnson Anticoagulants Product and Services
Table 25. Johnson & Johnson Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Bayer Basic Information, Manufacturing Base and Competitors
Table 27. Bayer Anticoagulants Major Business
Table 28. Bayer Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 29. Bayer SWOT Analysis
Table 30. Bayer Anticoagulants Product and Services
Table 31. Bayer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 33. Bristol-Myers Squibb Anticoagulants Major Business
Table 34. Bristol-Myers Squibb Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 35. Bristol-Myers Squibb SWOT Analysis
Table 36. Bristol-Myers Squibb Anticoagulants Product and Services
Table 37. Bristol-Myers Squibb Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 39. Boehringer Ingelheim Anticoagulants Major Business
Table 40. Boehringer Ingelheim Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 41. Boehringer Ingelheim SWOT Analysis
Table 42. Boehringer Ingelheim Anticoagulants Product and Services
Table 43. Boehringer Ingelheim Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Otsuka Basic Information, Manufacturing Base and Competitors
Table 45. Otsuka Anticoagulants Major Business
Table 46. Otsuka Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 47. Otsuka SWOT Analysis
Table 48. Otsuka Anticoagulants Product and Services
Table 49. Otsuka Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 51. AstraZeneca Anticoagulants Major Business
Table 52. AstraZeneca Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 53. AstraZeneca SWOT Analysis
Table 54. AstraZeneca Anticoagulants Product and Services
Table 55. AstraZeneca Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table 57. Genentech (Roche) Anticoagulants Major Business
Table 58. Genentech (Roche) Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 59. Genentech (Roche) SWOT Analysis
Table 60. Genentech (Roche) Anticoagulants Product and Services
Table 61. Genentech (Roche) Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Lilly Basic Information, Manufacturing Base and Competitors
Table 63. Lilly Anticoagulants Major Business
Table 64. Lilly Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 65. Lilly SWOT Analysis
Table 66. Lilly Anticoagulants Product and Services
Table 67. Lilly Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Pfizer Basic Information, Manufacturing Base and Competitors
Table 69. Pfizer Anticoagulants Major Business
Table 70. Pfizer Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 71. Pfizer SWOT Analysis
Table 72. Pfizer Anticoagulants Product and Services
Table 73. Pfizer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 75. Daiichi Sankyo Anticoagulants Major Business
Table 76. Daiichi Sankyo Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 77. Daiichi Sankyo SWOT Analysis
Table 78. Daiichi Sankyo Anticoagulants Product and Services
Table 79. Daiichi Sankyo Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. The Medicines Company Basic Information, Manufacturing Base and Competitors
Table 81. The Medicines Company Anticoagulants Major Business
Table 82. The Medicines Company Anticoagulants Total Revenue (USD Million) (2018-2019)
Table 83. The Medicines Company SWOT Analysis
Table 84. The Medicines Company Anticoagulants Product and Services
Table 85. The Medicines Company Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Global Anticoagulants Sales by Manufacturer (2018-2019) (K MT)
Table 87. Global Anticoagulants Revenue by Manufacturer (2018-2019) (USD Million)
Table 88. Global Anticoagulants Sales by Regions (2015-2020) (K MT)
Table 89. Global Anticoagulants Sales Market Share by Regions (2015-2020)
Table 90. Global Anticoagulants Revenue by Regions (2015-2020) (USD Million)
Table 91. North America Anticoagulants Sales by Countries (2015-2020) (K MT)
Table 92. North America Anticoagulants Sales Market Share by Countries (2015-2020)
Table 93. North America Anticoagulants Revenue by Countries (2015-2020) (USD Million)
Table 94. North America Anticoagulants Revenue Market Share by Countries (2015-2020)
Table 95. Europe Anticoagulants Sales by Countries (2015-2020) (K MT)
Table 96. Europe Anticoagulants Sales Market Share by Countries (2015-2020)
Table 97. Europe Anticoagulants Revenue by Countries (2015-2020) (USD Million)
Table 98. Asia-Pacific Anticoagulants Sales by Regions (2015-2020) (K MT)
Table 99. Asia-Pacific Anticoagulants Sales Market Share by Regions (2015-2020)
Table 100. Asia-Pacific Anticoagulants Revenue by Regions (2015-2020) (USD Million)
Table 101. South America Anticoagulants Sales by Countries (2015-2020) (K MT)
Table 102. South America Anticoagulants Sales Market Share by Countries (2015-2020)
Table 103. South America Anticoagulants Revenue by Countries (2015-2020) (USD Million)
Table 104. South America Anticoagulants Revenue Market Share by Countries (2015-2020)
Table 105. Middle East & Africa Anticoagulants Sales by Countries (2015-2020) (K MT)
Table 106. Middle East & Africa Anticoagulants Sales Market Share by Countries (2015-2020)
Table 107. Middle East & Africa Anticoagulants Revenue by Countries (2015-2020) (USD Million)
Table 108. Middle East & Africa Anticoagulants Revenue Market Share by Countries (2015-2020)
Table 109. Global Anticoagulants Sales by Type (2015-2020) (K MT)
Table 110. Global Anticoagulants Sales Share by Type (2015-2020)
Table 111. Global Anticoagulants Revenue by Type (2015-2020) (USD Million)
Table 112. Global Anticoagulants Revenue Share by Type (2015-2020)
Table 113. Global Anticoagulants Sales by Application (2015-2020) (K MT)
Table 114. Global Anticoagulants Sales Share by Application (2015-2020)
Table 115. Global Anticoagulants Sales Forecast by Regions (2021-2025) (K MT)
Table 116. Global Anticoagulants Market Share Forecast by Regions (2021-2025)
Table 117. Global Anticoagulants Sales Forecast by Type (2021-2025) (K MT)
Table 118. Global Anticoagulants Market Share Forecast by Type (2021-2025)
Table 119. Global Anticoagulants Sales Forecast by Application (2021-2025)
Table 120. Global Anticoagulants Market Share Forecast by Application (2021-2025)
Table 121. Direct Channel Pros & Cons
Table 122. Indirect Channel Pros & Cons
Table 123. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Anticoagulants Picture
Figure 2. Global Sales Market Share of Anticoagulants by Type in 2019
Figure 3. Platelet aggregation inhibitors (PAI) Picture
Figure 4. Low-molecular-weight Heparin (LMWH) Picture
Figure 5. Direct thrombin inhibitor (DTI) Picture
Figure 6. Direct factor Xa inhibitors (DFXa) Picture
Figure 7. Vitamin K antagonists (VKA) Picture
Figure 8. Others Picture
Figure 9. Anticoagulants Sales Market Share by Application in 2019
Figure 10. VTE Picture
Figure 11. ACS/MI Picture
Figure 12. AF Picture
Figure 13. Other Picture
Figure 14. Global Anticoagulants Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Anticoagulants Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Anticoagulants Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Anticoagulants Sales Market Share by Manufacturer in 2019
Figure 35. Global Anticoagulants Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Anticoagulants Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Anticoagulants Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 40. Global Anticoagulants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Anticoagulants Revenue Market Share by Regions (2015-2020)
Figure 42. Global Anticoagulants Revenue Market Share by Regions in 2018
Figure 43. North America Anticoagulants Sales and Growth Rate (2015-2020)
Figure 44. Europe Anticoagulants Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Anticoagulants Sales and Growth Rate (2015-2020)
Figure 46. South America Anticoagulants Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Anticoagulants Sales and Growth Rate (2015-2020)
Figure 48. North America Anticoagulants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Anticoagulants Sales Market Share by Countries (2015-2020)
Figure 50. North America Anticoagulants Sales Market Share by Countries in 2018
Figure 51. North America Anticoagulants Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Anticoagulants Revenue Market Share by Countries in 2018
Figure 53. United States Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Canada Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Mexico Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 56. Europe Anticoagulants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Anticoagulants Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Anticoagulants Revenue Market Share by Countries in 2019
Figure 59. Germany Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 60. UK Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 61. France Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Russia Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Italy Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Asia-Pacific Anticoagulants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Anticoagulants Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Anticoagulants Revenue Market Share by Regions 2019
Figure 67. China Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Japan Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Korea Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 70. India Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Southeast Asia Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 72. South America Anticoagulants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Anticoagulants Sales Market Share by Countries in 2019
Figure 74. South America Anticoagulants Revenue Market Share by Countries in 2019
Figure 75. Brazil Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Argentina Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Middle East and Africa Anticoagulants Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Anticoagulants Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Anticoagulants Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Anticoagulants Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Egypt Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Turkey Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 84. South Africa Anticoagulants Sales and Growth Rate (2015-2020) (K MT)
Figure 85. Global Anticoagulants Sales and Growth Rate (2021-2025) (K MT)
Figure 86. Global Anticoagulants Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Anticoagulants Market Forecast (2021-2025) (K MT)
Figure 88. Europe Sales Anticoagulants Market Forecast (2021-2025) (K MT)
Figure 89. Asia-Pacific Sales Anticoagulants Market Forecast (2021-2025) (K MT)
Figure 90. South America Sales Anticoagulants Market Forecast (2021-2025) (K MT)
Figure 91. Middle East & Africa Sales Anticoagulants Market Forecast (2021-2025) (K MT)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
注射型抗凝固剤の世界市場 2020年 Market Overview The Injectable Anticoagulants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 抗凝固薬の世界市場 2020年 Market Overview The global Anticoagulants Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anticoagulants Drug marke…
- 血小板凝集システムの世界市場 2020年 Market Overview The global Platelet Aggregation System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Platelet Aggregat…
- チロシンキナーゼ阻害剤の世界市場 2020年 Market Overview The global Tyrosine Kinase Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tyrosine Kinase In…
- 腫瘍壊死因子阻害薬の世界市場 2020年 Market Overview The global Tumor Necrosis Factor Inhibitors Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor N…